Aviva McPherron compensation by year
Orthofix Medical Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $447,297 |
| Bonus | $0 |
| Stock awards | $900,008 |
| Option awards | $300,001 |
| Non-equity incentive | $149,508 |
| Pension and deferred compensation | $0 |
| All other | $15,104 |
| Total | $1,811,906 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Orthofix Medical Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191716, and prior-year filings.
How this page was built: the Orthofix Medical Inc. filed document, accession 0001193125-26-191716. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 119,332 | $904,537 | — |
| PSU | 35,336 | $535,694 | — |
| RSU | 19,889 | $301,517 | — |
| RSU | 17,668 | $267,847 | — |
| Option | 41,908 | — | $16.98 |
| Option | 34,320 | — | $12.57 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Orthofix Medical Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed April 29, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-06-18 | Sale | — | 3,670 | $9.38 | 66,330 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Orthofix Medical’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Massimo Calafiore | President and Chief Executive Officer | $7,310,039 |
| Julie Andrews | Chief Financial Officer | $3,017,844 |
| J. Andrés Cedrón | Chief Legal Officer | $2,057,964 |
| Aviva McPherron · this page | President, Global Operations and Quality | $1,811,906 |
| Patrick Fisher | President, Global Biologics and Limb Reconstruction | $1,796,906 |
Aviva McPherron's compensation dossier, Orthofix Medical
You have read Aviva McPherron's totals and holdings. The dossier adds each equity grant Orthofix Medical disclosed for Aviva McPherron and Orthofix Medical's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Orthofix Medical compensation record
free company briefThis page is one person within Orthofix Medical's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Orthofix Medical proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Orthofix Medical's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Orthofix Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.